Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in children aged between 5 and 11.
Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in children aged between 5 and 11.
COVID-19 vaccine trials for kids 5-11 progressing
Missouri DESE assisting 2 Kansas City-area school districts facing lunch-supply issues